Tumor‐Specific Protein Induced in Situ Self‐Assembly of Peptide Drugs for Synergistic Mitochondria Disruption

Mitochondria‐targeted cancer therapy is an effective method for controlling tumor growth. However, the presence of repair mechanisms in tumor cells in response to mitochondrial damage poses significant challenges for treatment. By taking advantage of intracellular self‐assembly technology, a peptide...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Advanced materials (Weinheim) Ročník 37; číslo 3; s. e2413069
Hlavní autori:	Hao, Yi, Hou, Da‐Yong, Zhou, Lei, Fan, Yan‐Lei, Wu, Xiu‐Hai, Liu, Yi‐Xuan, Xu, Yin‐Sheng, Song, Ben‐Li, Yi, Li, Qiao, Zeng‐Ying, Wang, Hao, Xu, Shou‐Ping
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Germany Wiley Subscription Services, Inc 01.01.2025
Predmet:	Animals Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Cell Line, Tumor Cell membranes Control methods Damage Dimerization Disruption Drugs Epithelial-Mesenchymal Transition - drug effects Humans Mice Mitochondria Mitochondria - drug effects Mitochondria - metabolism Mucin-1 - chemistry Mucin-1 - metabolism Nanomaterials NF-kappa B - metabolism Peptides Peptides - chemistry Peptides - pharmacology Peptides - therapeutic use Reactive Oxygen Species - metabolism Self-assembly Tumors peptide nanomaterials synergy mitochondrial self‐assembly
ISSN:	0935-9648, 1521-4095, 1521-4095
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!